Baidu
map

Cell Reports:日研究发现导致神经病变性疼痛物质

2012-05-19 蓝建中 新华网

近日,日本九州大学副教授津田诚率领的研究小组发现,导致神经病变性疼痛的是一种编号为IRF8的蛋白质。相关研究报告发表在最新一期《细胞—报告》(Cell Reports)上。 神经病变性疼痛是由于癌症和糖尿病等原因损伤神经而导致的慢性疼痛,患者非常痛苦,甚至穿衣服时轻碰身体,都会非常疼痛。 此前的研究表明,神经损伤后脑和脊髓中的小神经胶质细胞过度活跃,会产生使神经兴奋的物质,从而引起疼痛。但是小

近日,日本九州大学副教授津田诚率领的研究小组发现,导致神经病变性疼痛的是一种编号为IRF8的蛋白质。相关研究报告发表在最新一期《细胞—报告》(Cell Reports)上。

神经病变性疼痛是由于癌症和糖尿病等原因损伤神经而导致的慢性疼痛,患者非常痛苦,甚至穿衣服时轻碰身体,都会非常疼痛。

此前的研究表明,神经损伤后脑和脊髓中的小神经胶质细胞过度活跃,会产生使神经兴奋的物质,从而引起疼痛。但是小神经胶质细胞为何会活跃的机制却一直没弄清。

津田诚等人在利用小鼠进行的实验中发现,IRF8蛋白质只存在于在小神胶质经细胞中。神经损伤后,小神经胶质细胞内这种蛋白质就会增加,处于活跃状态,发挥了激活小神经胶质细胞的“开关”作用。

全球约有2000万神经病变性疼痛患者,常用吗啡等麻醉药镇痛,但其效果有限而且会致人上瘾。津田诚指出:“通过遏制IRF8蛋白质的功能,就有可能缓和慢性疼痛。”研究小组今后准备继续进行研究,争取发掘现有药物遏制IRF8蛋白质的功能。(生物谷Bioon.com)


doi:10.1016/j.celrep.2012.02.014
PMC:

PMID:

IRF8 Is a Critical Transcription Factor for Transforming Microglia into a Reactive Phenotype

Takahiro Masuda, Makoto Tsuda, Ryohei Yoshinaga, Hidetoshi Tozaki-Saitoh, Keiko Ozato, Tomohiko Tamura, Kazuhide Inoue

Microglia become activated by multiple types of damage in the nervous system and play essential roles in neuronal pathologies. However, how microglia transform into reactive phenotypes is poorly understood. Here, we identify the transcription factor interferon regulatory factor 8 (IRF8) as a critical regulator of reactive microglia. Within the spinal cord, IRF8 expression was normally low; however, the expression was markedly upregulated in microglia, but not in neurons or astrocytes, after peripheral nerve injury (PNI). IRF8 overexpression in cultured microglia promoted the transcription of genes associated with reactive states; conversely, IRF8 deficiency prevented these gene expressions in the spinal cord following PNI. Furthermore, IRF8-deficient mice were resistant to neuropathic pain, a common sequela of PNI, and transferring IRF8-overexpressing microglia spinally to normal mice produced pain. Therefore, IRF8 may activate a program of gene expression that transforms microglia into a reactive phenotype. Our findings provide a newly observed mechanism for microglial activation.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1752967, encodeId=c6d91e529679b, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jun 24 10:15:00 CST 2012, time=2012-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958740, encodeId=45901958e40ba, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Aug 22 12:15:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868509, encodeId=475a186850978, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Oct 16 08:15:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463457, encodeId=dbe3146345e19, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491203, encodeId=cd3e149120365, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500306, encodeId=e751150030609, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1752967, encodeId=c6d91e529679b, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jun 24 10:15:00 CST 2012, time=2012-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958740, encodeId=45901958e40ba, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Aug 22 12:15:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868509, encodeId=475a186850978, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Oct 16 08:15:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463457, encodeId=dbe3146345e19, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491203, encodeId=cd3e149120365, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500306, encodeId=e751150030609, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2012-08-22 维他命
  3. [GetPortalCommentsPageByObjectIdResponse(id=1752967, encodeId=c6d91e529679b, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jun 24 10:15:00 CST 2012, time=2012-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958740, encodeId=45901958e40ba, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Aug 22 12:15:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868509, encodeId=475a186850978, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Oct 16 08:15:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463457, encodeId=dbe3146345e19, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491203, encodeId=cd3e149120365, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500306, encodeId=e751150030609, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1752967, encodeId=c6d91e529679b, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jun 24 10:15:00 CST 2012, time=2012-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958740, encodeId=45901958e40ba, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Aug 22 12:15:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868509, encodeId=475a186850978, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Oct 16 08:15:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463457, encodeId=dbe3146345e19, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491203, encodeId=cd3e149120365, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500306, encodeId=e751150030609, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2012-05-21 huangdf
  5. [GetPortalCommentsPageByObjectIdResponse(id=1752967, encodeId=c6d91e529679b, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jun 24 10:15:00 CST 2012, time=2012-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958740, encodeId=45901958e40ba, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Aug 22 12:15:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868509, encodeId=475a186850978, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Oct 16 08:15:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463457, encodeId=dbe3146345e19, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491203, encodeId=cd3e149120365, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500306, encodeId=e751150030609, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2012-05-21 axin012
  6. [GetPortalCommentsPageByObjectIdResponse(id=1752967, encodeId=c6d91e529679b, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jun 24 10:15:00 CST 2012, time=2012-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958740, encodeId=45901958e40ba, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Aug 22 12:15:00 CST 2012, time=2012-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868509, encodeId=475a186850978, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Oct 16 08:15:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463457, encodeId=dbe3146345e19, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491203, encodeId=cd3e149120365, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500306, encodeId=e751150030609, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]

相关资讯

Arch Neurol:探究与阿尔茨海默氏症有关的蛋白质

一项针对脑脊液蛋白与阿尔茨海默病相关的临床症状与认知正常的老年患者之间的关系的研究表明:β-淀粉样蛋白相关的临床病理的下降与P-tau蛋白磷酸化的tau蛋白升高有联系,相关研究论文发表在Archives of Neurology杂志上。 加州圣地亚哥医学院的大学Rahul S. Desikan医学博士和同事评估了107阿尔茨海默氏病患者个体。他们检查脑脊液(CSF)的tau蛋白181的磷酸化(P

Nat. Neurosci:GluK2是保护神经细胞的关键蛋白质

近日,神经科学家发现负责保护神经细胞的关键蛋白质,这一研究结果可能有助于开发出中风和癫痫的新疗法。 已发现的这一关键蛋白质激活后能保护在心脏衰竭或癫痫发作期间神经细胞免受损害,该蛋白能调节大脑中的神经细胞之间的信息传输。该研究由英国布里斯托尔大学神经科学家完成,并刊登在Nature Neuroscience杂志上。 布里斯托尔医学院教授Jeremy Henley和Jack Mellor博士领导

Neurology:日常体力活动或降低阿尔茨海默病风险

Neurology发表了一篇神经学的新研究,研究指出:日常体力活动可能降低各个年龄阶段阿尔茨海默病与认知下降的风险。日常体力活动主要包括运动、炒菜、洗碗、做卫生、打牌及手推轮椅,这些活动低成本、方便、无副作用,任何年龄的人都能做,鼓励不能参与正式运动的老人每天进行这些活动,会使他们从中受益,降低患阿尔茨海默病的风险。 该研究有716位老人参与,他们平均年龄82岁,无痴呆。为了客观测定体力活动,除

Arch. Neurol:眼球震颤或可作早期帕金森病的标志

  4月9日,《神经病学文献》(Archives of Neurology)在线发表的一项研究报告称,在对112例患者和60例对照者进行分析之后发现,眼球震颤或眼球固定不稳是帕金森病患者普遍存在的一种特异性很高的特征。因此,采用精准的眼球追踪技术来评价眼球运动参数将有助于帕金森病的早期诊断。 美国Hunter Holmes McGuire退伍军人医疗中心的George T. Gitc

2型糖尿病患者下肢神经传导异常率高于上肢

  最近,南京军区南京总医院神经内科的研究人员的一项研究显示,尽管受检时血糖控制良好,但依然有周围神经电生理异常变化。2型糖尿病患者下肢神经传导异常率高于上肢,尤以运动神经明显。病程是糖尿病周围神经损害的危险因素,随着病程增加神经传导异常率和损伤严重程度增高。该研究发表于2012年第3期《中风与神经疾病杂志》。   该研究旨在探讨2型糖尿病患者周围神经病变(DPN)的神经电生理特点及其与病程的关

Neuron:大脑AKT3基因突变易致侧巨脑症

近日,哈佛医学院儿童医院的研究者发现仅仅大脑组织的突变可引起侧巨脑症(HMG),这种侧巨脑症也就是一半大脑增大以及功能失调,最终导致智障以及严重癫痫症。研究者的这项研究刊登在了4月12日的国际杂志Neuron上,对于精神疾病的治疗提供了很好的线索和模板。大脑组织的突变可以由遗传产生也可以后天自发产生,遗传突变遍布于人体的全部细胞之中,但是一些自发的突变是在机体发育的过程中产生的,而且仅仅发生在某些

Baidu
map
Baidu
map
Baidu
map